Acute lymphoblastic leukaemia (ALL) is rarely seen in pregnancy. Massive hepatosplenomegaly as a presentation of ALL has not been described previously in any patient population. A 30yearold pregnant woman presented at 16 weeks' gestation with epistaxis, jaundice, diffuse abdominal pain and distension, massive hepatosplenomegaly and peripheral oedema. On the basis of blood tests, bone marrow biopsy and imaging, a diagnosis of ALL complicated by massive hepatosplenomegaly with splenic infarctions was made. The patient was referred to oncology for appropriate chemotherapy.
IN PRACTICE
Cancer in pregnancy is rare, occurring in about one in 1 000 preg nancies. [1] The most common malignancies in pregnancy are breast cancer, cervical cancer, melanoma, leukaemia and lymphoma. Specifically, acute leukaemia is extremely uncommon in pregnancy, with an incidence of 1 in 75 000. [2] Acute lymphoblastic leukaemia (ALL) accounts for 28% of cases of leukaemia diagnosed during pregnancy, the remainder being acute myeloid and chronic myeloid leukaemias. [3] Massive hepatosplenomegaly as a presentation of ALL has not been reported previously in any patient population. We describe the first case of massive hepatosplenomegaly in a pregnant patient with ALL.
Case report
A 30yearold pregnant woman, previously healthy, presented with a 3week history of nosebleeds, yellow discolouration of the eyes and skin, diffuse abdominal pain and distension, and swelling of the legs. The pain was worst in the left hypochondrium and was dull and constant. The epistaxis had worsened, prompting her to seek help at the referring hospital. She reported dyspnoea at rest and paroxysmal nocturnal dyspnoea. The urine was dark and the stools were pale. Fever, night sweats and weight loss of ~5 kg were also reported.
Clinical examination revealed marked pallor, without significant lymphadenopathy. Peripheral oedema and overt jaundice were noted. The urine was dark, with bilirubin present on dipstick examination. Her vital signs revealed a tachycardia (126 bpm), a blood pressure of 114/64 mmHg and a respiratory rate of 36 breaths per minute. Cardiovascular examination was remarkable only for an ejection systolic murmur over the base of the heart. The findings on respiratory examination were normal. The abdomen was distended, with significant tenderness on light palpation. Rebound tenderness but no rigidity was present. There was clinical hepatosplenomegaly, with a liver span of 26 cm in the midclavicular line and the spleen measuring 14.5 cm inferior to the lower rib margin. The uterus was palpable (about 16 18 weeks' gestation). Signs of ascites could not be elicited owing to the tenderness. Examination of the head and neck revealed no epistaxis at the time of examination, and no obvious nasal pathology. The findings on skin and musculoskeletal examination were normal. A chest radiograph and abdominal ultrasound scan were reque sted. An elevated diaphragm was noted on the chest radiograph (Fig. 1 ). An abdominal ultrasound scan revealed no thrombi in the inferior vena cava or the portal or iliac veins. The liver was enlarged (25 cm in the midclavicular line) with normal portal vein and hepatic vein flow. The gallbladder wall was thickened. The kidneys were normal in size. The spleen was enlarged at 19 × 9 cm. Ascites was present. A fetus was noted, about 16 weeks' gestational age, with a heart rate of 145 bpm. Despite the pregnancy, we elected to perform a computed tomography (CT) scan of the chest to exclude a pulmonary embolism. No pulmonary embolism was evident, and no lymphadenopathy was noted in the chest. The scan was extended to the abdomen to identify the cause of the abdominal pain and delineate the pathology better. It showed massive hepatosplenomegaly with multiple splenic infarctions (Fig. 2) . There was compression of the inferior vena cava (IVC) and features of portal hypertension. No abdominal lymphadenopathy was present.
A bone marrow aspirate was consistent with acute leukaemia, with 23% blast cells. In conjunction with the flow cytometry, the overall picture was suggestive of precursor Tcell ALL with aberrant expression of CD16.
A final diagnosis of precursor Tcell ALL in a pregnant patient, complicated by massive hepatosplenomegaly with multiple splenic infarctions, cholestasis and probable portal hypertension, was made. The patient was referred to oncology, where she was treated with steroids and combination chemotherapy including anthra cyclines.
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Discussion
This case represents a rare presentation of an uncommon mali gnancy in pregnancy. Massive hepatosplenomegaly, although common in chronic myeloid leukaemias, has not been described as a presentation of ALL at all. The most common listed causes of massive hepatosplenomegaly include chronic lymphoproliferative malignancies, infections (malaria, leishmaniasis) and glycogen storage diseases (Gaucher's disease). [4] In our case the probable causes of the massive hepatosplenomegaly were a combination of late presentation after symptom onset, leukaemic infiltration and secondary compression of the IVC with resultant portal hypertension.
The case highlights the importance of maintaining a high index of suspicion for uncommon causes of massive hepatosplenomegaly as well as rare malignancies in pregnancy. ALL is diagnosed occasionally in pregnancy. [5] Early diagnosis and treatment are advisable. Pregnancy itself does not alter the course of acute leukaemia, but urgent chemotherapy is essential to improve the outcome. Treatment in the first trimester carries a high risk of fetal anomalies and miscarriage. Leukapheresis may be considered in the first trimester to delay chemotherapy.
In recent years, numerous reports have addressed issues pertaining to chemotherapy in later stages of pregnancy.
[514] Chemotherapy was well tolerated by the majority of patients, with a low incidence of spontaneous abortion. Germann et al. [5] reported normal deli veries in 73% of 160 pregnant patients treated with anthracycline chemotherapy. Intensive chemotherapy in the second and third trimesters does not pose an inordinate risk to fetal or neonatal development, although increased rates of premature delivery and perinatal mortality, and lower birth weight for gestational age, have been noted. [514] A multidisciplinary approach involving the patient, obstetrician, physician, haematologist and oncologist is mandatory for optimal clinical outcome. 
IN PRACTICE
Funding. None.
Conflicts of interest.
None.
